ACC Action Center

Welcome to the ACC Action Center, bringing you the latest updates from the American College of Cardiology’s Annual Scientific Session & Expo, hosted in partnership with the World Congress of Cardiology. This collection will highlight emerging clinical data and explore the latest practice-changing advances in the field of cardiology.

LikeLikedUnlike

46-60 of 67

Cardio-Oncology: Key Clinical Data from ACC.23
ACC Action Center
Cardio-Oncology: Key Clinical Data from ACC.23
- Ana Barac, MD, PhD
  Peer
The Emerging Field of Cardio-Oncology: A Look at the Multidisciplinary Team
ACC Action Center
The Emerging Field of Cardio-Oncology: A Look at the Multidisciplinary Team
- Javed Butler, MD
  Peer
- Ana Barac, MD, PhD
  Peer
The STELLAR Trial: Key Data on Sotatercept for PAH
ACC Action Center
The STELLAR Trial: Key Data on Sotatercept for PAH
- Marius M. Hoeper, MD
  Peer
Insights on Statin Therapy & LDL Cholesterol from the CLEAR Outcomes Trial
ACC Action Center
Insights on Statin Therapy & LDL Cholesterol from the CLEAR Outcomes Trial
- Kausik Ray, MBChB, MD, MPhil
  Peer
Highlights from Day 3 of ACC.23
ACC Action Center
Highlights from Day 3 of ACC.23
Social Media & Heart Health: Insights from ACC.23
ACC Action Center
Social Media & Heart Health: Insights from ACC.23
advertisement
Exploring Clinical Data From Day 1 of ACC.23
ACC Action Center
Exploring Clinical Data From Day 1 of ACC.23
Developments in Cardiology from Day 2 of ACC.23
ACC Action Center
Developments in Cardiology from Day 2 of ACC.23
Anticipated Updates on Statin Intolerance at ACC 2023
ACC Action Center
Anticipated Updates on Statin Intolerance at ACC 2023
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
  Peer
- Kevin C. Maki, PhD, FNLA, CLS
  Peer
ACC.23: Here's What To Expect
ACC Action Center
ACC.23: Here's What To Expect
A First Clinical Trial Testing the Use of an H2S Donor After Heart Attack
ACC Action Center
A First Clinical Trial Testing the Use of an H2S Donor After Heart Attack
Reductions in LVOT Gradients, NYHA Class, & NT-proBNP with Cardiac Myosin Inhibitor in HCM
ACC Action Center
Reductions in LVOT Gradients, NYHA Class, & NT-proBNP with Cardiac Myosin Inhibitor in HCM
advertisement
Novel Form of CV Research with Dietary Education in the Grocery Store
ACC Action Center
Novel Form of CV Research with Dietary Education in the Grocery Store
Beginning of an Era: Treatment of Elevated Lp(a)
ACC Action Center
Beginning of an Era: Treatment of Elevated Lp(a)
PCSK9i Reduces Plaque Burden in Coronary Arteries
ACC Action Center
PCSK9i Reduces Plaque Burden in Coronary Arteries